CFMG & Wellpath in California — a documentary investigation · Article 009 of 100 · Series 1 — Corporate history and the making of an enterprise

From Chapter 11 to Local Government–California: The 2026 Reorganization of the Operating Layer

Published

20 September 2026, 6:00 PM PT

Content last changed

25 September 2026

Public-evidence cutoff

25 September 2026

Sources checked

25 September 2026

Record through

25 September 2026

Editorial status

Public-source editorial review complete

Evidence note. This article relies on public records and distinguishes established fact, party position, allegation, judicial finding, inference and unresolved question. Nothing here is a finding that any identified corporation or individual violated California law unless a cited adjudicative source expressly says so.

Opening frame#

From Chapter 11 to Local Government–California: The 2026 Reorganization of the Operating Layer is fundamentally an identity-and-continuity inquiry. The legal entity, the management platform, the public brand, and the county-facing operation may overlap without becoming interchangeable. The analysis therefore asks what changed, what persisted, and which primary records are capable of proving each proposition.

The governing question is narrow: What changed when Wellpath created a California-specific operating division, and what did not? The article connects that question to juridical identity, operational integration, professional authority, ownership and succession, practical exit rights, and demonstrated veto power only where the evidence makes those connections material.

I. The Question and the Public Record#

The relevant public record is best read cumulatively. No single branding statement, county agenda item, corporate filing, bankruptcy disclosure, or management agreement resolves the entire relationship. The evidentiary value comes from comparing documents created for different purposes and asking whether they converge on the same allocation of identity, authority, economics, and professional responsibility.

Wellpath now publicly describes CFMG as a physician-owned affiliate#

In March 2026, Wellpath announced a new California-focused operating division called Local Government-California . In the same release, Wellpath called CFMG a Wellpath affiliate and stated in a footnote that CFMG is a professional corporation owned by licensed physicians and affiliated with Wellpath’s management-services organization. Wellpath also described the use of enterprise data infrastructure across its affiliates. Source: Wellpath, Mar. 13, 2026

That is the company’s current public description of the relationship. It is useful evidence of how Wellpath describes the architecture; it is not independent proof of the identity of CFMG’s individual shareholders or of how professional authority functions in every decision.

Rule 7.1 “corporate parent” anomaly#

Several 2023–2024 Northern District dockets show Wellpath LLC identifying CFMG as a “Corporate Parent.” Other filings identify CFMG merely as an “Other Affiliate,” and a 2026 CFMG disclosure reciprocally identifies Wellpath LLC as an “Other Affiliate.” These labels also conflict with the bankruptcy ownership chart and current physician-ownership description.

This is a high-priority reconciliation issue. It is not yet proof that CFMG owned Wellpath LLC, and it should not be dismissed as a typo without the actual disclosure forms.

Employment-control cluster#

Overfield — one of the strongest public physician-employment cases. The record treats the physician as a CFMG employee while enterprise-associated HR personnel supply corporate testimony concerning termination. The current public record does not establish that the termination arose from clinical judgment; contrary testimony matters.

Vizgaudis-Gomez — separate CFMG/Wellpath defendants in an employment setting; high potential but do not infer joint employment before the Mendoza declaration and merits record are reviewed.

Wagner and related Nevada County records — useful for workforce and program allocation rather than automatic CPOM conclusions.

Enterprise quality system#

The reviewed public litigation establishes a substantive enterprise clinical-quality system, including:

• Clinical Mortality Review;

• Administrative Mortality Review;

• Part III / Form 01c;

• local RHA/HSA drafting;

• Wellpath Corporate Office receipt;

• Patient Safety Committee;

• CQI / Quality Innovations;

• PSES;

• external PSO reporting;

• County/client participation;

• root-cause analysis;

• improvement planning.

This defeats the early simplistic model “CFMG = clinical, Wellpath = only administrative.”

MSA continuity#

The Plan uses a broad assumption mechanism for executory contracts not rejected or otherwise treated. The CFMG MSA was filed in the bankruptcy. Targeted review has not found CFMG on the first rejection schedule, and post-emergence operations strongly support continuity. A later El Dorado administrative-expense filing states that debtor-side obligations connected with a CFMG medical-services contract were assumed. Exact final confirmation still requires all rejection schedules and any post-emergence amendment/ratification.

II. Structural and Historical Context#

Quality-control cluster#

Hultman — substantive Wellpath Clinical Mortality Review, Administrative Mortality Review, Patient Safety Committee, root-cause analysis, and improvement planning.

K.C. — local RHA/HSA → Wellpath Corporate Office quality workflow, CQI hierarchy, Part III/Form 01c, client participation, PSES/PSO evidence, and the 2023 policy-review breakpoint.

Kartchner — CFMG withholds/controls Part III in discovery and asserts PSQIA protections; court orders production. Strong evidence of CFMG institutional quality role plus Wellpath enterprise architecture.

Johnson/Shasta — unusually rich historical set connecting CFMG finances, policies, staffing, corrective action, mortality review, and Raymond Herr.

III. The Control and Governance Analysis#

2026: Wellpath formalizes a California operating division#

In March 2026, Wellpath created a California-specific Local Government-California division.

The company publicly described CFMG as a Wellpath affiliate and said CFMG is a professional corporation owned by licensed physicians and affiliated with Wellpath’s management-services organization. Wellpath also described its California affiliates as drawing on enterprise data maintained in a national correctional-healthcare data warehouse. Wellpath, Mar. 13, 2026

That current statement ties together the historical threads:

• CFMG remains part of the California structure;

• Wellpath presents it as an affiliate, not merely a historical predecessor;

• Wellpath supplies the larger management and data platform.

Inside the CFMG–Wellpath Management Architecture#

The 2012 CFMG Management Services Agreement is unusually revealing. It formally reserves professional medicine to CFMG while assigning the management company a wide operating role across employment, finance, records, information systems, insurance, claims and other administrative functions. The contract therefore supports both professional separation and deep operational integration.

Many discussions of management-services organizations fail because they start with a conclusion.

Either the MSO is described as a routine back-office vendor, or its broad involvement is treated as proof that it controls the medical practice.

CFMG’s publicly filed management agreement makes both shortcuts difficult.

The contract contains unusually explicit language protecting physician authority.

It also gives the manager unusually broad responsibilities.

The document is therefore best read as an authority map .

Layer one: explicit professional independence#

The agreement begins with formal safeguards.

It describes the parties as independent contractors. It says CFMG is solely and exclusively in control of professional medical services and says the management company will not control the methods by which physicians practice medicine.

It also states that the manager will not provide a service that would itself constitute clinical practice or professional medical services.

Those provisions are substantial evidence of the intended legal allocation .

They should not be dismissed merely because the same contract contains extensive management powers.

At the same time, formal language is not proof of how every later decision actually operated.

That distinction — intended allocation versus actual practice — is the central theme of this investigation.

Layer two: an exclusive management relationship#

The agreement makes the management company CFMG’s exclusive provider of management services .

The manager is authorized to perform those services in the manner it considers reasonably appropriate to meet the day-to-day business needs of CFMG, subject to the agreement and applicable law.

This is not a narrow payroll contract.

Exhibit B describes a broad operating platform.

Among the functions assigned to the manager are categories involving:

• legal and regulatory support;

• accounting and finance;

• payroll and tax administration;

• benefit-plan administration;

• administrative personnel;

• information technology;

• database and connectivity services;

• electronic medical-record implementation and maintenance;

• insurance and risk management;

• billing and collections;

• record-maintenance infrastructure;

• supplies and support services;

• purchasing;

• marketing and bidding assistance;

• and office support.

The correct conclusion is straightforward:

The contract contemplated extensive administrative integration from the beginning.

That does not answer who had final professional authority.

Layer three: the Company Designee#

One of the most important governance provisions appears early in the agreement.

When the contract calls for CFMG approval, consent, direction or other action — unless the agreement says otherwise — action by the person designated as CFMG’s chief executive officer under its bylaws, termed the Company Designee , can constitute action by CFMG.

The agreement also provides for a management-company representative to attend and participate in certain meetings involving the Company Designee and equityholders, in a non-voting capacity.

This is a governance-adjacent mechanism.

It proves that the management relationship reached beyond isolated back-office tasks.

It does not prove that the manager had a vote or could compel a professional decision.

The public investigation therefore needs to identify:

• who served as Company Designee over time;

• what authority CFMG’s bylaws gave that role;

• and what categories of decisions moved through that approval channel.

Layer four: physician staffing — recommendation versus final decision#

The agreement creates a useful natural test of authority.

It says the management company will periodically review and make recommendations regarding the appropriate number of physicians needed to operate the practice sites.

But it also says final determinations concerning physician staffing levels are the responsibility of CFMG.

That division can be written as:

Wellpath/manager: review + recommend

CFMG: final determination

This is exactly the kind of allocation that should be tested in public records.

Routine agreement between the two actors tells us little.

A disagreement would tell us much more.

If a management recommendation was rejected or modified by CFMG and the CFMG decision was implemented, that would be strong evidence of practical professional veto.

If the opposite occurred, it would raise a different question.

At present, the public contract establishes the formal allocation. Later pages will search for implementation evidence.

Layer seven: finance and cash management#

The agreement also creates substantial financial integration.

The management-services package includes:

• accounting;

• financial reporting;

• invoicing;

• payroll/tax support;

• budgeting;

• cash management;

• benefit and bonus-plan administration.

Exhibit D provides for a management fee calculated as a percentage of adjusted gross revenues — identified in the filed version as 18% — and states that the parties regarded the fee as fair-market-value compensation for management services.

The same exhibit authorizes specified disbursement mechanics and grants the management company a security interest in CFMG assets to the extent permitted by law, with references to broader credit arrangements.

These are economically important provisions.

They are not, by themselves, proof of professional control.

But they make separate questions worth investigating:

• How economically dependent was CFMG on the management structure?

• What happened if the management agreement ended?

• What did the referenced deficit-funding and credit documents provide?

• Could financial remedies affect the practical ability to change managers?

Those questions require the related contracts, not inference from the MSA alone.

Layer twelve: the current Wellpath description#

Wellpath’s March 2026 California operating-division announcement provides a useful modern cross-check.

Wellpath publicly calls CFMG:

• a Wellpath affiliate;

• a professional corporation;

• owned by licensed physicians;

• affiliated with Wellpath’s MSO.

It also describes California operations as leveraging enterprise data infrastructure across Wellpath affiliates. Wellpath, Mar. 13, 2026

That description is consistent with the broad architecture reflected in the older MSA:

professional corporation + management platform .

The remaining question is how that architecture functions in practice.

Chapter 11 and post-bankruptcy era#

November 2024. Wellpath Holdings and debtor affiliates enter Chapter 11. CFMG is repeatedly treated as a nondebtor professional corporation while debtors argue that CFMG-related litigation can affect debtor insurance, indemnity, defense, and estate interests.

2025–2026. California litigation begins correcting old shorthand. Cases increasingly distinguish CFMG from Wellpath LLC and WMI, substitute the Liquidating Trust for debtor entities, and add or retain CFMG separately.

March 2026. Wellpath announces Local Government–California under Jessica Mazlum and publicly describes CFMG as a physician-owned professional corporation affiliated with Wellpath's management-services organization.

1. Current public records continue to identify CFMG as county contractor and/or labor-law employer in counties including Merced and Lake, while Wellpath remains the enterprise/MSO platform and Zenova appears as a current virtual-care platform.

September 2026. Fresno's Amendment XIII to its CFMG agreement (County File 26-0855) adds CalAIM Justice-Involved prerelease services and raises the cumulative contract ceiling by $6,104,438 to $400,479,492. The post–September 22 County record assigns it Agreement No. 26-459 and Resolution No. 26-329 and lists a Digital Signature Certificate among the filed materials; the Legistar “Final action” field remains blank, so Board approval is not characterized here as conclusively recorded from that page alone. The recommended action names CFMG as counterparty, while the County's discussion describes Wellpath as providing and coordinating the new services and Medusind, Inc. as Wellpath's subcontracted billing vendor. (Updated 25 September 2026.)

Zenova#

Zenova Management, LLC and Zenova Telehealth, LLC appear in the Wellpath bankruptcy group. Zenova Physicians, P.C. appears separately in professional-corporation contexts. Current Zenova materials describe virtual clinical services. CFMG/Wellpath proposals increasingly incorporate Zenova, and Bazzel has appeared using a Zenova email domain in CFMG contract-related records. This establishes a legitimate current affiliation/service-delivery inquiry, not Zenova ownership or control of CFMG.

Formal professional reservations#

The MSA expressly preserves a professional-corporation structure. CFMG retains professional medical authority and meaningful functions involving physician staffing, clinical quality, credentialing, corrective action, impaired-physician matters, and policies of a purely medical character. The manager is not authorized to practice medicine.

These provisions are real contrary evidence to any categorical theory that CFMG had no professional role.

Four/five-layer authority model#

Fresno contains at least:

• County / Sheriff / Hall — facility access, security, custody, contract oversight, remedial obligations, some staffing/service requirements.

• CFMG — formal professional corporation, County contractor, substantial formal employer evidence, claimed physician-governance authority.

• Wellpath / Local Government–California / enterprise operations — HR, payroll administration, credentialing administration, IT/access, claims, defense, enterprise records and policy systems.

• Enterprise clinical leadership — quality, patient-safety, clinical programs, physician executives.

• Individual clinicians — patient-specific diagnosis, treatment, referral, escalation, documentation.

A sixth platform layer may exist where Zenova or another affiliate supplies service-line care.

Current contract continuity#

Fresno's formal jail-health agreement continues in CFMG's name through major amendments. Amendment XII, approved December 3, 2024, extended the agreement through June 30, 2029 with optional years. Amendment XIII (County File 26-0855) adds CalAIM Justice-Involved prerelease services and raises the cumulative ceiling by $6,104,438 to $400,479,492. The post–September 22, 2026 County record assigns it Agreement No. 26-459 and Resolution No. 26-329 and lists a Digital Signature Certificate among the filed materials. The Legistar page's “Final action” field remains blank, so this investigation does not characterize Board approval as conclusively recorded from that page alone.

This is powerful current evidence of CFMG juridical continuity after bankruptcy and after creation of Local Government–California.

September 2026: Amendment XIII exposes the contracting/operating split#

The post–September 22, 2026 Fresno County legislative record materially sharpens the CFMG–Wellpath allocation-of-function analysis. County File 26-0855 now assigns the transaction Agreement No. 26-459 and Resolution No. 26-329 and lists a Digital Signature Certificate among the filed materials. The Legistar page's “Final action” field nevertheless remains blank. This investigation therefore does not characterize Board approval as conclusively recorded from that page alone.

The formal recommended action remains an amendment to the County's agreement with California Forensic Medical Group, Incorporated. The amendment would add CalAIM Justice-Involved prerelease services for adults detained at the Fresno County Jail and increase maximum compensation by $6,104,438 to $400,479,492.

The County's substantive discussion, however, uses the Wellpath name for the operating layer. It says the amendment will authorize Wellpath to provide the CalAIM Justice-Involved reentry services; that Wellpath will collaborate with WestCare California and the County's managed-care plans to develop reentry care plans and coordinate services; and that Wellpath will ensure that its staff are credentialed to bill Medi-Cal and trained to support accurate, complete billable documentation.

The same record identifies Medusind, Inc. as Wellpath's subcontracted billing vendor. According to the County, Medusind will audit and perform quality assurance on claims for medical, mental-health and substance-use services delivered within the 90-day prerelease window. Medusind is to receive 7% of gross revenue collected by the County. The County estimates billing-administration fees of up to approximately $114,323 for the partial FY 2026–27 period, $190,624 in FY 2027–28 and $232,099 in FY 2028–29.

The result is one of the clearest current Fresno records of a layered operating structure:

County ↔ CFMG as the named contractual counterparty → Wellpath as the County-described program operator/coordinator → Medusind as Wellpath's subcontracted billing vendor → County as recipient of Medi-Cal reimbursement.

That sequence is more probative than casual “CFMG/Wellpath” branding because the same government record assigns different functions to the two names. It supports the proposition that CFMG remains juridically significant as the County-facing professional-corporation contractor while Wellpath performs or coordinates substantial operational functions underneath the agreement.

The record also says Amendment XII had previously been approved with “CFMG (Wellpath),” while Amendment XIII's formal contracting title remains CFMG. That difference reinforces the investigation's standing rule: trade identity, contracting identity, operating identity, employer identity and professional-authority identity must be coded separately rather than collapsed into a single corporate label.

What this record establishes#

It establishes that, in Fresno County's September 2026 public record, CFMG continues to appear as the juridical contracting entity while the County expressly describes Wellpath as providing and coordinating significant CalAIM implementation functions. It also supplies current evidence that Wellpath coordinates at least portions of the administrative infrastructure surrounding credentialing, billable-documentation training and the relationship with a third-party billing vendor.

What this record does not establish#

It does not establish that Wellpath owns CFMG; that CFMG lacks genuine physician ownership; that CFMG is a sham corporation; that Wellpath exercises physician-reserved clinical judgment; or that Wellpath is the legal employer of every person the County calls “its staff.” The phrase “Wellpath will also ensure that its staff are credentialed to bill Medi-Cal” should be treated as an operational statement requiring reconciliation with the worker-specific payroll, W-2, EDD, NLRB, contract and professional-employer record.

The document therefore does not answer “CFMG or Wellpath?” with one name. It shows why the binary itself can be misleading: the County contracts through CFMG while describing Wellpath as the organization carrying out substantial implementation, coordination and billing-administration functions.

Source: Fresno County File 26-0855 — Amendment XIII (Agreement No. 26-459; Resolution No. 26-329) · full text · Board meeting, 22 Sept 2026 (Item 35). Primary government record; accessed 25 September 2026.

The post–September 22 record is a direct test of what the March 2026 Local Government–California reorganization means in practice. The County continues to put the professional contract in CFMG's name while describing Wellpath as the actor that will implement and coordinate the new program. That supports an operating-layer interpretation of Local Government–California without proving that the division possesses CFMG's physician-reserved authority.

Sonoma — clearest current PC/MSO recital#

Sonoma's 2026 MAT agreement is among the strongest current documents because it names CFMG as contractor and separately identifies Wellpath LLC as the Management Services Organization providing functions such as accounting, regulatory support, claims/litigation assistance, payroll, invoicing, risk management, and HR. The same contract separately gives the County powers over staffing, audits, security, and removal of assigned personnel.

This is a clean example of distributed authority , not one actor controlling everything.

Program allocation is itself a control question#

Across counties, JBCT and related services appear under different entities. This raises questions about who decides:

• which PC carries a program;

• which entity employs staff;

• how workers transfer when a program moves;

• which PC holds clinical responsibility;

• whether enterprise economics or professional governance drives the allocation.

No general conclusion should be drawn without program-specific contracts.

Era 5 — Post-emergence 2025–2026: Reconstruction and Local Government–California#

After confirmation and emergence, California cases increasingly corrected old entity assumptions and added CFMG separately.

In March 2026, Wellpath announced a new Local Government–California operating division led by Jessica Mazlum. Wellpath’s own announcement states that CFMG is a professional corporation owned by licensed physicians and affiliated with Wellpath’s management-services organization.

Primary source:

https://wellpathcare.com/2026/03/13/wellpath-announces-creation-of-a-new-operating-division-in-california-appoints-new-highly-experienced-leader/

The post-bankruptcy question is therefore not whether CFMG exists. It plainly does. The question is whether the reorganized management enterprise changed, preserved, or intensified the pre-existing allocation of actual authority.

POST-BANKRUPTCY LOCAL GOVERNMENT–CALIFORNIA#

Wellpath’s creation of Local Government–California in 2026 is not merely a branding event.

It creates a new level of organizational hierarchy through which California local-government operations are coordinated.

The announcement:

• identifies Jessica Mazlum as division president;

• describes CFMG as physician-owned;

• places the California operation within the broader Wellpath platform;

• emphasizes shared enterprise resources/data capabilities.

The research question is not whether Mazlum is a physician. A nonphysician can lawfully lead an MSO operating division.

The question is how the new division allocates authority to CFMG’s physician governance.

Required records:

• Local Government–California org chart;

• reporting line from CFMG president/shareholders;

• division president authority matrix;

• California chief clinical/medical leadership;

• who approves physician hiring/termination;

• who signs county bids;

• who approves pricing;

• who owns clinical policies;

• who approves utilization-management rules;

• who controls EHR permissions;

• who can override site medical directors.

The post-bankruptcy reorganization gives the record a natural before/after comparison.

THE 2026 LOCAL GOVERNMENT–CALIFORNIA DIVISION IS ANOTHER NATURAL EXPERIMENT#

In March 2026 Wellpath announced a new California operating division, Local Government–California, while describing CFMG as a physician-owned professional corporation affiliated with Wellpath's MSO.

The organizational change raises a parallel set of structural questions:

• Did CFMG board/shareholders approve the new division's authority over CFMG-supported contracts?

• Did the MSA change?

• Did compensation or management-fee schedules change?

• Did a new delegation matrix issue?

• Did California leadership obtain authority from CFMG or only from Wellpath?

• Did the Company Designee change?

• Were stock-transfer or governance agreements amended?

A divisional reorganization inside the MSO does not automatically affect CFMG's professional control.

But if practical authority changed, the CFMG corporate record should show how it was authorized.

THE MARCH 2026 LOCAL GOVERNMENT–CALIFORNIA REORGANIZATION CREATES A SECOND GOVERNANCE STRESS TEST#

On March 13, 2026, Wellpath announced creation of a new operating division:

Local Government–California

and appointed Jessica Mazlum as Division President.

Wellpath expressly described CFMG as:

• a Wellpath affiliate;

• a professional corporation;

• owned by licensed physicians;

• affiliated with Wellpath’s management-services organization.

Primary source:

https://wellpathcare.com/2026/03/13/wellpath-announces-creation-of-a-new-operating-division-in-california-appoints-new-highly-experienced-leader/

Wellpath also said the California operation would leverage the company’s enterprise data infrastructure.

This creates a new post-bankruptcy governance question:

What CFMG corporate action authorized the role of the Local Government–California division in the operations supporting CFMG’s California contracts?

Possible answers include:

• no CFMG approval was needed because the division was merely an internal MSO reorganization;

• CFMG approved a delegation;

• the existing MSA already allowed the reorganization;

• or amendments/delegation matrices were executed.

The public announcement does not answer that.

Again, the issue is not whether a nonphysician can lead an MSO division. A nonphysician can.

The question is where her authority ends and CFMG physician authority begins.

LOCAL GOVERNMENT–CALIFORNIA SHOULD BE ANALYZED AS AN INTERNAL LAYER ABOVE OR WITHIN THE CONTINUING MSA#

Wellpath’s March 2026 creation of Local Government–California under Jessica Mazlum did not publicly announce termination of the CFMG MSA, a new CFMG professional corporation, a new California physician owner, or replacement of Wellpath LLC as MSO.

Instead, the announcement continued to describe CFMG as the physician-owned professional corporation affiliated with Wellpath’s MSO.

That suggests the new division is best analyzed, absent contrary documents, as an internal operating layer within the reorganized Wellpath management platform rather than a new legal contracting substitute for CFMG.

The crucial question is delegation:

Which powers were moved internally within Wellpath, and which powers remained with CFMG physician governance?

IV. Contrary Evidence, Limits, and Competing Explanations#

A disciplined analysis must begin its limiting case with the strongest contrary evidence: Counterevidence to any simple narrative includes CFMG's continued legal existence, the distinction between enterprise transactions and PC shares, and the fact that later branding can obscure rather than replace juridical identity.

V. Missing Documents and Falsification Tests#

The record remains incomplete in material respects. Key unresolved points include exact corporate succession, historical ownership, and whether later enterprise changes altered only management or also professional-corporation governance.

The national enterprise changed in 2018#

In October 2018, H.I.G. announced that an affiliate had acquired Correct Care Solutions and combined it with Correctional Medical Group Companies. H.I.G. described CMGC as having been founded in 1983 as California Forensic Medical Group. The combined enterprise was national in scope. Source: H.I.G. Capital, Oct. 1, 2018

What the announcement does not say is equally important: it does not establish that the California professional corporation itself ceased to exist, legally merged into Wellpath LLC, or transferred its professional-corporation shares to a non-physician.

The CFMG management agreement was assigned to Wellpath LLC in 2019#

A January 1, 2019 assignment, later filed in Wellpath’s Chapter 11 case and made publicly available, transferred CFMG’s management-services agreement from its prior management entity to Wellpath LLC. The document says the assignment was undertaken for the efficiency of administering management functions. It also states that the assignment included related or incidental instruments, including “relevant stock transfer restriction agreements.” Source: 2019 MSA Assignment

The assignment establishes the existence or reference to those related agreements. It does not disclose their operative terms. The ownership-and-succession consequences of those documents therefore remain an open public-record question.

Layer eleven: the 2019 assignment and stock-transfer restrictions#

The January 2019 assignment is one of the most consequential public documents.

It transferred the management agreement to Wellpath LLC.

It also says the assignment included related or incidental instruments, including relevant stock transfer restriction agreements .

That phrase should be handled with care.

It establishes a documentary trail.

It does not establish what rights the stock-transfer instruments contained.

The public investigation should therefore resist the temptation to fill the gap with facts from unrelated “friendly PC” cases.

Instead, the proper question is simple:

What do the CFMG-specific stock-transfer and succession documents actually say?

Until those documents are located, the answer remains open.

The structural-control question#

The core structural question is not whether Wellpath legally owned CFMG.

The strongest currently available evidence cuts against that simplistic proposition.

In November 2024, Wellpath board co-chair Kip Hallman publicly stated that CFMG was a wholly separate entity, owned primarily by physicians, with no ownership overlap with Wellpath. Santa Barbara County later described CFMG as a separate physician-owned entity that used Wellpath to manage business aspects. CFMG remained a nondebtor professional corporation during the Wellpath Chapter 11 case.

Those facts are material.

But ownership of stock is only one form of control.

California's 2026 enforcement posture requires examination of whether a nonprofessional enterprise can exercise control through:

• contractual replacement rights;

• shareholder succession mechanisms;

• long-term exclusive management arrangements;

• financing;

• security interests;

• bank-account authority;

• control of assets or infrastructure;

• assignment rights;

• practical inability of the physician corporation to replace the manager.

The central the prior analysis inquiry therefore is:

Could CFMG physician owners independently reject, replace, or terminate Wellpath and continue operating a viable California medical corporation?

THE 2025 RESTRUCTURING changed OWNERSHIP OF THE MANAGEMENT ENTERPRISE — not PROVEN CFMG STOCK OWNERSHIP#

Wellpath announced that it emerged from Chapter 11 in May 2025 and transitioned ownership to a group of its current and former lenders.

Primary Wellpath announcement:

https://wellpathcare.com/2025/05/12/wellpath-emerges-from-chapter-11-to-lead-a-new-era-in-correctional-healthcare/

Prospect Capital SEC filings independently confirm that its prepetition Wellpath debt was restructured on May 9, 2025 into new debt and equity positions in New WPCC Parent, LLC , plus an interest in the Wellpath Liquidating Trust.

Primary SEC record:

https://www.sec.gov/Archives/edgar/data/1287032/000128703226000164/psec-20260331.htm

Those records are important because they independently confirm the lender-to-equity restructuring.

They do not establish that New WPCC Parent acquired CFMG professional-corporation stock.

The entity distinction developed in the prior analysis remains critical:

New WPCC Parent / reorganized Wellpath enterprise ≠ automatically California Forensic Medical Group, Incorporated .

Any transfer of CFMG physician shares must be proved independently.

What the continuity chain does not yet prove#

The record reviewed here does not yet establish the exact Docket 194 line for the CFMG MSA, the proposed CFMG Cure Cost, whether CFMG filed a cure objection, whether CFMG expressly consented to assumption, whether the MSA was amended during Chapter 11, whether CFMG’s board ratified the post-emergence relationship, whether CFMG obtained independent counsel, whether management fees changed, whether the Deficit Funding Loan Agreement continued unchanged, whether the security interest/UCC package continued unchanged, whether the CFMG Stock Transfer Agreement was itself assumed under Article V.F, whether any post-emergence stock agreement was executed, or whether the Local Government–California reorganization required or received CFMG corporate approval.

Those remain targeted gaps rather than reasons to discard the continuity conclusion.

K. Ownership and succession remain the most important unresolved structural issue#

the prior analysis established that the 2019 assignment transferred the CFMG MSA together with related instruments expressly including relevant stock-transfer restriction agreements.

The enterprise bankruptcy record independently described Wellpath’s friendly-PC model as using stock-transfer agreements to manage ownership succession and qualification.

But the CFMG-specific operative instrument has not been authenticated in the current record.

Accordingly, the investigation cannot responsibly state whether Wellpath held:

• owner nomination rights;

• approval rights;

• veto rights;

• replacement rights;

• stock options;

• proxies;

• powers of attorney;

• mandatory-transfer rights;

• rights triggered by physician employment;

• or rights tied to MSA termination.

This missing instrument is especially important after California’s 2026 enforcement focus on physician-owner replacement and MSO entrenchment.

The correct final classification is:

TIER-ONE OPEN STRUCTURAL EVIDENCE — potentially decisive, not yet proved.

VI. Why the Issue Matters#

The stakes are practical rather than semantic. Counties need to know which entity is accountable for contracted performance; clinicians need to know where professional authority resides; courts and regulators need entity-specific evidence rather than brand shorthand; and the public needs a record that distinguishes corporate continuity from operational integration. Those distinctions become most important when the actors disagree, when a contract changes hands, when a professional decision conflicts with an economic preference, or when litigation requires a precise answer to who had authority to act.

POST-BANKRUPTCY CALIFORNIA: LOCAL GOVERNMENT–CALIFORNIA#

In March 2026, Wellpath publicly announced a new Local Government–California operating division led by Jessica Mazlum. Wellpath simultaneously described CFMG as a physician-owned professional corporation affiliated with Wellpath's management-services organization.

This is the clearest current public articulation of the model:

CFMG = physician professional corporation

Wellpath = management-services / operating platform

The new division raises important continuity questions:

• Did the underlying CFMG MSA change after bankruptcy?

• Did ownership or control rights change?

• Did new lenders inherit contractual rights over the MSO that affect CFMG?

• Did CFMG physician ownership change?

• What authority does the Local Government–California president have over California clinical operations?

• What authority remains exclusively with CFMG physicians?

• Who reports to Jessica Mazlum?

• Who reports to CFMG's physician officers?

• Who approves physician employment, workload, compensation, and discipline?

These questions should be tested through 2026 county procurement records and current corporate filings.

VII. Falsification Tests and Evidentiary Limits Note#

The record does not support be read as establishing an unproven motive, an undisclosed shareholder, an unlawful medical override, or a legal conclusion that a court or regulator has not made. The strongest version of the thesis is the one that survives the missing-document test: identify the instrument, minutes, ledger, delegation, approval record, or disagreement event that would materially change the conclusion, then state what has and has not been found. If later primary evidence contradicts a proposition stated here, the correction should be made at the proposition level rather than defended through branding or organizational shorthand.

VIII. Related Articles#

• Article 008 — The Other 'CFMG': Why Wellpath CFMG, Inc. Is Not Automatically California Forensic Medical Group

• Article 010 — The 2026 California Stack: CFMG, Wellpath Operations, Enterprise Clinical Leadership, Zenova, and the County

• Article 007 — Medical Group vs Management Group: The Name Collision That Distorts the Historical Record

What the 2026 record adds to the reorganisation picture#

This article traces the path from Chapter 11 to the 2026 California configuration. The sweep of 20 September 2026 fills in several public details and adds one development the original analysis predates.

The reorganisation chronology is well documented in public reporting. The petition was filed on 12 November 2024. Reporting describes debtor-in-possession financing of roughly $522 million, a January 2025 approval to separate the behavioural-health division to lenders in exchange for cancelling approximately $375 million of debt, plan confirmation on 1 May 2025, and emergence on 12 May 2025 with ownership transitioning to a lender group and a debt reduction on the order of $550 million.

The development the original analysis predates is regulatory rather than corporate. Senate Bill 351 and Assembly Bill 1415 were signed in October 2025 and took effect on 1 January 2026 — that is, between emergence and the configuration this article describes. The first codifies California’s corporate-practice-of-medicine prohibition; the second extends Office of Health Care Affordability reporting to private-equity and management-services transactions.

The sequencing matters to this article’s argument. A reorganisation that concluded in May 2025 produced a structure that, from January 2026, operates under a codified standard which did not exist when the structure was designed. Whether the post-emergence California configuration satisfies that standard is not a question the reorganisation record answers, because the reorganisation record predates the standard.

The usual limits apply. An ownership transition at the enterprise level does not establish any change in the governance of a California professional corporation, which is a separate legal entity; the statutes operate prospectively and do not reach earlier arrangements; and no public enforcement action concerning these entities has been located in this sweep.

IX. Emergence did not reset the California architecture to zero#

The post-emergence period should be analyzed as a continuity-and-change problem. Wellpath's Chapter 11 emergence altered ownership and capital structure on the debtor side, but the California record does not show a complete replacement of the professional-corporation framework. Current county contracts, labor records, management relationships, and Wellpath's own 2026 description indicate substantial continuity in the way CFMG remains embedded in the California operation.

That does not mean nothing changed. A reorganization can preserve a contract while changing who controls the manager, how debt is financed, which executives hold authority, and how service lines are organized. The March 2026 creation of a Local Government-California division is therefore important evidence of post-emergence operating design. It demonstrates that the reorganized enterprise chose to create a California-specific operating layer rather than merely resume the prepetition structure without modification.

The division announcement should be read carefully. It is a corporate statement, not a judicial finding. Yet its timing makes it highly relevant: it is the enterprise's own contemporary description after Chapter 11. Where it describes CFMG as a physician-owned professional corporation affiliated with a Wellpath management-services organization, that formulation supports continuing PC-MSO architecture and undercuts simplistic claims that CFMG disappeared into Wellpath.

Continuity must be tested function by function#

The useful post-emergence questions are operational. Who signs county amendments? Which entity employs which clinicians? Who administers HR, payroll, benefits, claims, data, and technology? Who approves professional policy? Who owns CFMG shares? Who can replace the manager? Which entity contracts for telehealth or other specialized services? A single reorganization press release cannot answer all of those questions.

County records are especially helpful because they show whether CFMG continued to be the juridical counterparty. Labor proceedings show employer identity in a different legal forum. The 2012 MSA and 2019 assignment show the inherited management framework. Bankruptcy filings show which entities were debtors and how economic interests were affected. The 2026 operating announcement shows how the reorganized enterprise publicly describes itself. The architecture emerges from convergence among those records, not from any one source.

The strongest lawful explanation#

The strongest lawful explanation is that Chapter 11 restructured the upstream Wellpath enterprise while preserving compliant state-law professional entities and their management agreements. Under that model, the creation of Local Government-California is a business reorganization of the management platform, not a transfer of professional ownership. Shared executives, systems, and branding are expected because the MSO exists to provide those services.

The strongest investigative concern is whether post-emergence changes increased or altered practical control without corresponding public governance changes. If the new California division gained authority over physician hiring for competence, clinical discipline, peer review, professional policy, or owner succession, that would require much closer scrutiny. Public titles alone do not establish such authority.

The records that would resolve the post-emergence question#

The highest-value documents are any post-emergence amendments to the CFMG MSA; current CFMG bylaws and officer/director resolutions; current shareholder and stock-transfer records; delegation matrices between Local Government-California and CFMG; clinical-policy approval charters; and any transition documents issued when the new division was created. Those materials would show whether 2026 represented a branding/operations change or a deeper governance change.

The current evidence supports a measured conclusion: emergence changed the debtor-side enterprise and its ownership, but the California professional-corporation structure demonstrably survived in material respects. The next inquiry is not whether CFMG survived, but what powers remained with CFMG after the reorganized Wellpath platform was rebuilt around it.

X. A post-emergence continuity ledger#

The 2025-2026 record can be organized into a continuity ledger with four columns: prepetition feature; bankruptcy treatment; post-emergence evidence; unresolved change. For CFMG's legal existence, the prepetition feature is the professional corporation and county contracting identity; the post-emergence evidence includes continuing county and labor references. For management, the prepetition feature is the Wellpath LLC manager role under the 2019 assignment; the post-emergence evidence includes Wellpath's current California operating structure. For enterprise ownership, Chapter 11 clearly changed the debtor-side ownership. For CFMG share ownership, the public record remains incomplete. For clinical governance, prepetition MSA reservations exist; the post-emergence delegation and board materials remain the high-value target.

This ledger prevents a common analytical error: treating bankruptcy emergence as if it either changed everything or changed nothing. Reorganization operates instrument by instrument. Some contracts are assumed, others rejected or amended; ownership may change upstream; operational divisions may be reorganized; nondebtor entities may continue uninterrupted. The factual question for each CFMG relationship is therefore whether the specific right or obligation survived, changed, or was replaced.

The 2026 California division creates a new layer without answering the old ownership question#

The Local Government-California announcement matters precisely because it is post-emergence. It identifies a new operating layer and a current executive responsible for California local-government operations. That is strong evidence about management organization. It does not answer who owns CFMG shares, who elects its board, or who has final authority over a physician-reserved decision. Those questions belong to different records.

The distinction should also govern future reporting. If a 2026 county document is signed by a CFMG physician officer, that is evidence of CFMG corporate action. If a Wellpath division executive negotiates operational terms, that is evidence of management authority. If enterprise clinical leadership develops a program, that is evidence of clinical influence. The analysis must resist converting any one of those facts into universal control.

Bankruptcy creates a natural experiment for dependence#

A reorganization can also reveal dependence because contracts and services must be preserved, rejected, transferred, or renegotiated. If CFMG continued to function through the debtor restructuring with the same management agreement and systems, that is evidence of continuity and integration. If it had independent ability to select a new manager but chose not to, that could support a conventional business explanation. If it had no realistic ability to change managers because essential rights were tied to the enterprise, that would be more significant to practical control. The public record is not yet complete enough to choose between those explanations categorically.

The analysis therefore must conclude with a document request rather than a slogan: current MSA and amendments, shareholder ledger, board and officer resolutions, division delegations, data and transition rights, and any post-emergence clinical-governance charter. Those records would identify what actually survived emergence and what merely appears continuous from the outside.

The post-emergence period creates a before-and-after test#

The strongest way to evaluate 2026 is to compare functions before and after emergence. If the same CFMG officers, county signatures, employer records, management agreement, and professional-approval processes continue, continuity is more than branding. If new delegation instruments, new professional entities, or new policy-approval routes appear, those changes should be identified explicitly rather than absorbed into a generic “Wellpath reorganized” narrative.

A before-and-after table should therefore be maintained for contracting, employment, professional governance, management services, quality, claims, data, and ownership. The table need not assume that change is suspicious. Reorganizations normally change reporting lines and business units. Its purpose is to prevent a current structure from being projected backward and to prevent historical arrangements from being assumed to survive unchanged.

The March 2026 California announcement is particularly useful as a temporal marker. It provides a public date at which the reorganized enterprise chose to describe its California model. Records created after that date can be tested against the description. If they consistently show CFMG as the professional corporation and Wellpath as the management platform, the description gains weight. If they reveal materially different authority, the discrepancy becomes a specific reporting issue.

Conclusion#

Article 009 should be published only at the level of confidence the record supports. The controlling proposition is the one stated in the question presented above; adjacent issues such as ownership, employer status, professional authority, bankruptcy treatment, and branding should remain separate unless a primary source supplies the bridge. The strongest contrary evidence belongs in the article, not in an editorial footnote, and any unresolved ownership, delegation, succession, or decision-chain record should remain identified as a document target rather than converted into a factual assertion.

Sources cited in this section#

1. Source: Wellpath, Mar. 13, 2026 wellpathcare.com — https://wellpathcare.com/2026/03/13/wellpath-announces-creation-of-a-new-operating-division-in-california-appoints-new-highly-experienced-leader/
2. Source: H.I.G. Capital, Oct. 1, 2018 hig.com — https://hig.com/news/correct-care-solutions-and-correctional-medical-group-companies-join-forces-to-deliver-best-in-class-healthcare/
3. Source: 2019 MSA Assignment www.prisonlegalnews.org — https://www.prisonlegalnews.org/media/publications/California\_Forensic\_Medical\_Group\_Assignment\_of\_Management\_Services\_Agreement.pdf

Sources and authorities#

The matters and instruments below are those this article’s analysis rests on. Each is recorded with its evidentiary class: a judicial order decides, a party stipulation records an agreement, an attributed characterisation reports what someone said, and an executed instrument establishes terms rather than conduct.

Litigation and enforcement#

• Overfield v. Wellpath Community Care, LLC, E.D. Cal. No. 2:24-cv-00199-TLN-AC, Document 63 (16 June 2025) and Filing 87 (11 August 2026) — CFMG and Wellpath entities separately named; discovery and Rule 30(b)(6) deposition ordered concerning a CFMG physician termination.
• Estate of Hultman v. County of Ventura, C.D. Cal. No. CV 21-06280-DSF-RAO, 2022 WL 2101723 (16 May 2022) — mortality-review and patient-safety litigation establishing elements of the clinical mortality-review structure.
• Estate of Kartchner v. County of Merced, E.D. Cal. No. 1:23-cv-01672-KES-EGC, Document 95 (3 August 2026) — discovery record involving CFMG’s assertion of patient-safety protection over mortality-review material.
• Johnson v. County of Alameda, N.D. Cal. No. 3:23-cv-04069-CRB, Filing 76 (23 March 2026) — stipulation correcting an earlier pleading that described Wellpath Management, Inc. as previously named CFMG; records that CFMG is a separate organization and is not a debtor.
• Beckner v. County of Santa Cruz, N.D. Cal. No. 5:23-cv-05032-NW, Document 160 (26 March 2026) — judicial order separately identifying the CFMG defendants, noting a discharge order as to Wellpath entities, and separately adjudicating CFMG motions.

Instruments and statute#

• In re Wellpath Holdings, Inc., Bankr. S.D. Tex. No. 24-90533 — petition filed 11 November 2024; amended professional-corporation order, Docket 1473 (19 February 2025), identifying eighteen professional corporations including CFMG; plan confirmed 1 May 2025; effective 9 May 2025; emergence announced 12 May 2025.
• California Forensic Medical Group Management Services Agreement, 31 December 2012 — filed in the Wellpath Chapter 11 proceeding at Docket 827-1. Reserves professional medical judgment, utilization-review and quality-assurance guidelines, physician corrective action, impaired-physician matters and pure-medical policies to the professional corporation; assigns extensive administrative functions to the manager; declares void any management act constituting the practice of medicine.
• Assignment of Management Services Agreement, effective 1 January 2019 — identifies CFMG as Company, Wellpath LLC as incoming Manager, and Wellpath Management, Inc. (formerly Correctional Medical Group Companies, Inc., formerly California Forensic Management Group, Inc.) as Outgoing Manager. References related stock-transfer restriction instruments.
• Senate Bill 351 (2025), effective 1 January 2026 — codifies California’s corporate-practice-of-medicine prohibition previously resting on Business and Professions Code sections 2052 and 2400 as interpreted by case law and Medical Board guidance.
• Assembly Bill 1415 (2025), effective 1 January 2026 — extends Office of Health Care Affordability reporting to private-equity groups and management-services organizations.
• California Business and Professions Code sections 2052 and 2400 — unlicensed practice of medicine; prohibition on corporate practice.

Authorities relied on#

The matters and instruments below are those this article’s analysis rests on. Each is recorded with its evidentiary class: a judicial order decides, a party stipulation records an agreement, an attributed characterisation reports what someone said, and an executed instrument establishes terms rather than conduct.

Litigation and enforcement#

• Overfield v. Wellpath Community Care, LLC, E.D. Cal. No. 2:24-cv-00199-TLN-AC, Document 63 (16 June 2025) and Filing 87 (11 August 2026) — CFMG and Wellpath entities separately named; discovery and Rule 30(b)(6) deposition ordered concerning a CFMG physician termination.
• Estate of Hultman v. County of Ventura, C.D. Cal. No. CV 21-06280-DSF-RAO, 2022 WL 2101723 (16 May 2022) — mortality-review and patient-safety litigation establishing elements of the clinical mortality-review structure.
• Estate of Kartchner v. County of Merced, E.D. Cal. No. 1:23-cv-01672-KES-EGC, Document 95 (3 August 2026) — discovery record involving CFMG’s assertion of patient-safety protection over mortality-review material.
• Johnson v. County of Alameda, N.D. Cal. No. 3:23-cv-04069-CRB, Filing 76 (23 March 2026) — stipulation correcting an earlier pleading that described Wellpath Management, Inc. as previously named CFMG; records that CFMG is a separate organization and is not a debtor.
• Beckner v. County of Santa Cruz, N.D. Cal. No. 5:23-cv-05032-NW, Document 160 (26 March 2026) — judicial order separately identifying the CFMG defendants, noting a discharge order as to Wellpath entities, and separately adjudicating CFMG motions.

Instruments and statute#

• In re Wellpath Holdings, Inc., Bankr. S.D. Tex. No. 24-90533 — petition filed 11 November 2024; amended professional-corporation order, Docket 1473 (19 February 2025), identifying eighteen professional corporations including CFMG; plan confirmed 1 May 2025; effective 9 May 2025; emergence announced 12 May 2025.
• California Forensic Medical Group Management Services Agreement, 31 December 2012 — filed in the Wellpath Chapter 11 proceeding at Docket 827-1. Reserves professional medical judgment, utilization-review and quality-assurance guidelines, physician corrective action, impaired-physician matters and pure-medical policies to the professional corporation; assigns extensive administrative functions to the manager; declares void any management act constituting the practice of medicine.
• Assignment of Management Services Agreement, effective 1 January 2019 — identifies CFMG as Company, Wellpath LLC as incoming Manager, and Wellpath Management, Inc. (formerly Correctional Medical Group Companies, Inc., formerly California Forensic Management Group, Inc.) as Outgoing Manager. References related stock-transfer restriction instruments.
• Senate Bill 351 (2025), effective 1 January 2026 — codifies California’s corporate-practice-of-medicine prohibition previously resting on Business and Professions Code sections 2052 and 2400 as interpreted by case law and Medical Board guidance.
• Assembly Bill 1415 (2025), effective 1 January 2026 — extends Office of Health Care Affordability reporting to private-equity groups and management-services organizations.
• California Business and Professions Code sections 2052 and 2400 — unlicensed practice of medicine; prohibition on corporate practice.